← Evidence map

ArticleeLife2018

The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells.

Sean W Fanning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

63 papers cite itlatest 60 shown

2018
…
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30489256